Seek Returns logo

ASND vs. IRTC: A Head-to-Head Stock Comparison

Updated

Here’s a clear look at ASND and IRTC, comparing key factors like performance, valuation metrics, dividends, and financial strength. It’s built for investors or anyone curious to see how these two stocks match up.

Company Overview

ASND dominates in value with a market cap of 9.55 billion USD, eclipsing IRTC’s 4.47 billion USD by roughly 2.14×.

IRTC carries a higher beta at 1.34, indicating it’s more sensitive to market moves, while ASND remains steadier at 0.40.

ASND trades as an ADR, giving U.S. investors a simple on-ramp to its foreign shares, while IRTC remains a standard domestic listing.

SymbolASNDIRTC
Company NameAscendis Pharma A/SiRhythm Technologies, Inc.
CountryDKUS
SectorHealthcareHealthcare
IndustryBiotechnologyMedical - Devices
CEOMr. Jan Moller MikkelsenMr. Quentin S. Blackford
Price158.1 USD139.87 USD
Market Cap9.55 billion USD4.47 billion USD
Beta0.401.34
ExchangeNASDAQNASDAQ
IPO DateJanuary 28, 2015October 20, 2016
ADRYesNo

Performance Comparison

This chart compares the performance of ASND and IRTC over the past year by tracking the growth of an initial $10,000 investment in each (starting one year ago).

Hover over the lines to see the investment’s value and total return (%) at specific dates.

Data is adjusted for dividends and splits.

Valuation Metrics Comparison

The section examines key financial ratios to assess the valuation of ASND and IRTC based on earnings, cash flow, sales, and book value. Pay attention to the following notable points where extreme values stand out.

  • Neither ASND nor IRTC turned a profit—both carry negative P/E ratios of -24.55 and -44.94, underscoring continued losses that pressure their valuations.
  • Analysts assign negative forward PEG ratios to both ASND (-2.23) and IRTC (-3.27), suggesting expectation of shrinking or negative earnings in the upcoming period—a worrying sign for their profit outlook.
  • ASND has a negative P/B ratio of -44.20, indicating its liabilities exceed assets (negative equity). IRTC, with a P/B of 50.98, maintains positive shareholder equity.
  • ASND has a negative Price-to-Free Cash Flow ratio of -27.43, signaling it consumed more cash than it produced over the last year—an important liquidity warning. In contrast, IRTC (P/FCF 320.26) indicates positive free cash flow generation.
SymbolASNDIRTC
Price-to-Earnings Ratio (P/E, TTM)-24.55-44.94
Forward PEG Ratio (TTM)-2.23-3.27
Price-to-Sales Ratio (P/S, TTM)22.897.22
Price-to-Book Ratio (P/B, TTM)-44.2050.98
Price-to-Free Cash Flow Ratio (P/FCF, TTM)-27.43320.26
EV-to-EBITDA (TTM)-35.74-68.66
EV-to-Sales (TTM)23.787.80
EV-to-Free Cash Flow (TTM)-28.50346.10

Dividend Comparison

Neither ASND nor IRTC currently pays a dividend yield; this often indicates they are reinvesting earnings for growth, prioritizing long-term expansion over immediate cash returns to shareholders.

SymbolASNDIRTC
Dividend Yield (TTM)0.00%0.00%

Financial Strength Metrics Comparison

This section dives into the financial resilience of ASND and IRTC, spotlighting key metrics like liquidity, leverage, and debt coverage. Check out the standout observations below where notable differences or extremes pop up.

  • ASND’s quick ratio of 0.71 suggests it may struggle to cover immediate liabilities without selling inventory or raising cash, whereas IRTC at 5.58 maintains a comfortable buffer of liquid assets.
  • ASND shows negative equity (debt-to-equity ratio -4.46), while IRTC is heavily leveraged (8.49), illustrating two different balance-sheet risks.
  • Both ASND and IRTC report negative interest coverage ratios (-3.72, -16.44), meaning EBIT itself is negative—neither can cover interest, a critical solvency warning.
SymbolASNDIRTC
Current Ratio (TTM)1.045.71
Quick Ratio (TTM)0.715.58
Debt-to-Equity Ratio (TTM)-4.468.49
Debt-to-Assets Ratio (TTM)0.800.79
Interest Coverage Ratio (TTM)-3.72-16.44